2019
DOI: 10.1039/c9md00169g
|View full text |Cite
|
Sign up to set email alerts
|

Prodrug strategies for targeted therapy triggered by reactive oxygen species

Abstract: A comprehensive review of ROS-activated produg strategies for targeted therapy, including state-of-the-art and future perspectives.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
73
0
2

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 77 publications
(75 citation statements)
references
References 147 publications
(170 reference statements)
0
73
0
2
Order By: Relevance
“…Thus, the phenol of Pi103 was chosen as the point for attachment to the self-cyclizing portion of the molecule to make a ROS-sensitive PI3K prodrug. Detailed synthetic procedures, yields, and spectroscopic data including 1 H-NMR, 13 C-NMR, and highresolution MS are provided in Supplementary Information. Reaction of 1 with ROS is expected to release Pi103 and form a non-cytotoxic aromatic system (black, Figure 2C).…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…Thus, the phenol of Pi103 was chosen as the point for attachment to the self-cyclizing portion of the molecule to make a ROS-sensitive PI3K prodrug. Detailed synthetic procedures, yields, and spectroscopic data including 1 H-NMR, 13 C-NMR, and highresolution MS are provided in Supplementary Information. Reaction of 1 with ROS is expected to release Pi103 and form a non-cytotoxic aromatic system (black, Figure 2C).…”
Section: Resultsmentioning
confidence: 99%
“…Compound 1 was synthesized in three steps, starting from commercially available Pi103, in an overall yield of 60 % (Scheme 1). Detailed synthetic procedures, yields, and spectroscopic data including 1 H-NMR, 13 C-NMR, and highresolution MS are provided in Supplementary Information.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations